CLINICAL_TRIALS
trial_result
· 2022-04-19
Clinical Trial Update: Fenofibrate for Patients With COVID-19 Requiring Hospitalization [Phase 3]
Summary
Phase 3 trial update for fenofibrate in hospitalized COVID-19 patients, status currently unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yaakov Nahmias | Conditions: Corona Virus Disease (COVID-19), Respiratory Distress Syndrome | Phase 3 | Status: UNKNOWN